9.4 Hypoglycemia (Especially with Concomitant Insulin or Sulfonylureas) When used alone, this isn't typically a problem, but it can cause low blood sugar more often when taken with other medications that lower blood sugar levels
Mitokondri iinde oksijenin varlnda yaklan ya asitleri ATP reterek enerji olarak kullanlmak zere vcutta dolama sokulmaktadr
Cell Immunol
Common side effects include: Gastrointestinal: Nausea, diarrhea, constipation, and abdominal pain (most common, usually transient) Decreased appetite: Expected and generally beneficial for weight management Injection site reactions: Mild redness or irritation at the injection site Rare but serious risks include: Pancreatitis (inflammation of the pancreas seek immediate medical attention for severe abdominal pain) Gallbladder disease Potential thyroid tumor risk (based on animal studies
Combining GLP-1s with Menopause Care Hormone therapy is the most effective treatment for many menopause symptoms, but GLP-1 receptor agonists may have a place in therapy for women with more significant risk factors related to metabolic health
The adjusted hazard ratio for women specifically was 2.08 (95% CI: 1.173.72) a statistically meaningful difference
